Home/Filings/4/0000891293-17-000105
4//SEC Filing

SINGER JACK W 4

Accession 0000891293-17-000105

CIK 0000891293other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 3:16 PM ET

Size

5.4 KB

Accession

0000891293-17-000105

Insider Transaction Report

Form 4
Period: 2017-09-29
SINGER JACK W
EVP, Chief Medical Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2017-09-29+115,000115,000 total
    Exercise: $3.19Exp: 2027-09-29Common Stock (115,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest in six equal semi-annual installments over a three-year period beginning September 29, 2017 subject to continued employment by CTIC through the applicable vesting dates.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeother

Related Parties

1
  • filerCIK 0001204264

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 3:16 PM ET
Size
5.4 KB